Fajardo, Kyzine .

HRN: 21-48-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2022
CEFUROXIME 750MG (VIAL)
06/23/2022
06/29/2022
IVT
200mg
Q8
PCAP C
Waiting Final Action 
06/28/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/28/2022
07/04/2022
IVTT
530mg
Q8
Pcap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: